Fenwick & West

🌟 We are honored to announce that Fenwick has been recognized in the 2024 Chambers and Partners USA guide! 🌟 Congratulations to our dedicated teams and thank you to the wonderful clients who trust us to support their business goals. This year, we were ranked across 27 practice areas, with 54 of our lawyers receiving individual rankings, including five partners earning prestigious Band 1 recognitions in their respective practices. Learn more about the rankings here: https://bit.ly/3ySPuF2 #ChambersUSA2024 #ChambersandPartners #LegalAwards

As May sprung into action, so did Fenwick's corporate team, handling two of the largest VC-backed financings and advising on over $4 billion in total activity. From venture investments to major mergers and acquisitions, the team's efforts propelled our clients' ambitions to new heights. 🚀 #CapitalMarkets #MergersAcquisitionsDivestitures #VentureCapital

🌊 The creative juices were flowing on day 3 of NY TECH WEEK by a16z as founders, investors, and creators turned it into a powerhouse of ideas, diving deep into the potential of AI in content creation, distribution, and curation. 💡 Industry pioneers Marissa Daisy Firke (Dirt), Preeya Goenka 🐝 (beehiiv), Ben-Zion Benkhin (WOMBO.ai), Jamie Wilkinson (Glif), and Megh Vakharia (SymphonyOS) explored the evolution of the creative stack from creation through distribution. 🔥 A highlight of the night was Fenwick’s Vejay Lalla, alongside Evan Ari Kelman (ScriptGen), addressing the critical legal aspects of AI in content creation, delving into pressing issues around identity and intellectual property that are top of mind for the creative and technology communities alike. A big thanks to Artist and the Machine, Spice Capital and NeueHouse for an incredible event! How do you see the future of AI shaping content creation? #NYTechWeek #ArtificialIntelligence #Creators

It was a day of women at NY TECH WEEK by a16z! Here’s a snapshot: 👩⚕️ Future of Women's Health Roundtable - Longevity, AI, and an Election Year co-hosted with Emmeline Ventures 💡 Emmeline Ventures, Ema - The AI for Women, Celeste, and Lōvu Health explored the integration of AI in women's health, addressing vital issues such as data gaps, personalized treatments, and the ethical use of AI to enhance maternal healthcare and accessibility. 💡Synastry Capital, Portfolia, and the Center for Reproductive Rights tackled the adverse effects of restrictive policies, the role of the private sector in healthcare advocacy, and how democracy and innovation interact to shape effective policies. 🚀 Breaking Barriers: Transparent Talks Among Female Entrepreneurs & Investors co-hosted with The Female Founder Collective and Amplifyher Ventures 💡 The Female Founder Collective, Amplifyher Ventures, Live Tinted, and Hill House Home talked about overcoming the unique challenges faced by female founders and investors, including navigating Series A funding, to mastering product-market fit, and the value of experienced legal advice. 💡Sarah Fergusson Chambless spoke with Brooke Baldwin, former CNN reporter and author of the best-selling book "Huddle: How Women Unlock Their Collective Power" in a candid conversation about the importance of connection and finding your community. What inspired you? #NYTechWeek #InvestinWomen

AI and predictive algorithms in health IT are facing new levels of transparency 🌐 Fenwick's Sari Heller Ratican, JD, LL.M, Jennifer Yoo, Alberto Tohme, and Sam Dodson explore the Health & Human Services’ Final Rule and the crucial steps in assessing compliance. 🌟 Enhanced Certification & Transparency Criteria 📋 New Certified Health IT Reporting Criteria 🔒 Enhanced Information Blocking Requirements 📈 Adoption of USCDI Version 3 To learn more, check out the full article at this link: https://bit.ly/3x3LSiL #Healthcare #HealthTech #AI

🏙️ Day 2 at NY TECH WEEK by a16z explored the future of tech, health, and the environment! Here’s a quick recap: 🌍City Futures: Healthtech and Climatetech Intersections 💠 Oriana Fuentes (Mika Health) and Chethan Sarabu, MD, FAMIA, FAAPC (Climate Health Innovation & Learning Lab) set the stage on the dynamics between climate and health. 💠 Lacy Shelby, PLA (The City University of New York) discussed the challenges and opportunities at the intersection of climate change and public health, highlighting how tech can address these issues. 💠 Evan Bienstock (Fenwick) and Ben Furnas (The 2030 Project: A Cornell University Climate Initiative) emphasized the critical role of innovation in reducing greenhouse gas emissions, enhancing urban resilience, and addressing climate inequality. 💠 Sara Holoubek (Luminary Labs), Jenessa Olson (ecologicca), Joel Cesare (BlocPower), and Joyce Tong Oelrich (Fenwick) highlighted the urgent need for integrated approaches in climate and health tech, and how their companies are driving change in this space. 🤖 State of AI: What's Next? 💠 Andrew Chen (Andreessen Horowitz) and Ian Goldstein (Fenwick) dove into the integration of AI in daily life and its critical role in the NYC tech ecosystem. 💠 Their conversation covered innovation vs. regulation, the importance of open standards for sustainable growth, and the exciting convergence of gaming and entertainment. What was your #NYTechWeek Day 2 highlight? #ArtificialIntelligence #Climatetech #Healthtech

🎉A huge congratulations to our client, Databricks, on another exciting milestone!🎉 Databricks has entered into a definitive agreement to acquire cloud-native data platform Tabular, further enhancing its data and AI capabilities. Together, Databricks and Tabular will aim to deliver data compatibility and openness by making open data lakehouse formats Delta Lake and Iceberg interoperable over time. We are thrilled to have supported Databricks in this significant step forward. Read more about the acquisition and what it means for the future of data management and AI: https://bit.ly/3RdSQIX #DataAI #Acquisitions

AI-assisted inventions require strategic patenting. 🤖📏 Fenwick IP partners Robert Hulse, Stuart Meyer, and associate Michael Saffron shared valuable insights in a recent webinar, including: 🔑 Human contribution is crucial for patentability. 🚫 Avoid asking AI to "solve" the problem. 🏗️ Refine and improve on AI drafts. 🧠 Training a bespoke AI model can lead to inventorship. 🔍 Mind the duty to disclose when applying for a patent. 📝 Stay up-to-date and discuss recommended practices with your attorney. Watch the full webinar here: https://bit.ly/49oisZI #AI #ArtificialIntelligence #Invention

Climate change remains a pressing issue, but the "Green Premium" presents a unique set of challenges for advocates. 🌎 #ICYMI In an article for Medium, partner Evan Bienstock shed light on: 🌍The Green Premium and the challenges it poses for environmentally friendly practices 🍀Reframing The Green Premium to be a driver of innovation 💲Creating sustainable solutions while minimizing costs 🔍And much more Learn more here: https://bit.ly/4aJ4HFH #ClimateChange #TheGreenPremium #Climate

Congrats to our client Royalty Pharma (Nasdaq: RPRX) on two recent transactions: its royalty acquisition agreement with Agios Pharmaceuticals and its strategic collaboration with Cytokinetics (Nasdaq: CYTK)! Royalty Pharma acquired Agios’ royalty on Servier’s vorasidenib, an oral, selective, highly brain-penetrant dual inhibitor of mutant isocitrate dehydrogenase 1 and 2 (IDH1/2) enzymes for the treatment of IDH-mutant diffuse glioma, a progressive and incurable brain tumor. Royalty Pharma also entered into an agreement with Cytokinetics that will support the commercial launch of the small molecule therapeutic aficamten for treating hypertrophic cardiomyopathy, advance Cytokinetics’ research and development pipeline, and diversify Cytokinetics’ access to capital. The Fenwick teams providing intellectual property diligence for Royalty Pharma were led by Carl Morales. Explore the deal details here: https://lnkd.in/eicr-kGu #FenwickForLifeSciences #LifeSciences